Medicine and Dentistry
Aplastic Anemia
100%
Fludarabine
100%
Conditioning
88%
Influenza
66%
Cyclophosphamide
55%
Graft Versus Host Reaction
55%
Transplantation
44%
Overall Survival
44%
Disease Free Survival
33%
Cyclosporine
33%
Engraftment
33%
Thymocyte Antibody
33%
Platelet
22%
Erythrocyte
22%
Graft Failure
22%
Prophylaxis
22%
Hematopoietic Stem Cell Transplantation
22%
Recurrence Free Survival
22%
Infection
11%
Hematopoietic Stem Cell
11%
Stem Cell
11%
Disease Duration
11%
Low Drug Dose
11%
Neutrophil
11%
Thrombocyte Transfusion
11%
Long Term Survival
11%
Methotrexate
11%
Peripheral Blood Stem Cell
11%
Chronic Graft Versus Host Disease
11%
Age
11%
Alloimmunization
11%
5 Nitro 2 (3 Phenylpropylamino)benzoic Acid
11%
Immunology and Microbiology
Conditioning
100%
Aplastic Anemia
100%
Influenza
75%
Graft-Versus-Host Disease
62%
Cyclophosphamide
62%
Overall Survival
50%
Transplant Procedure
50%
Platelet
37%
Anti-Thymocyte Globulin
37%
Ciclosporin
37%
Engraftment
37%
Disease Free Survival
37%
Hematopoietic Stem Cell Transplantation
25%
Recurrence Free Survival
25%
Erythrocyte
25%
Neutrophil
12%
Hematopoietic Stem Cell
12%
Low Drug Dose
12%
Stem Cell
12%
Peripheral Blood Stem Cell
12%
Chronic Graft Versus Host Disease
12%
Long Term Survival
12%
Methotrexate
12%
Age
12%
Pharmacology, Toxicology and Pharmaceutical Science
Aplastic Anemia
100%
Fludarabine
100%
Influenza
66%
Cyclophosphamide
55%
Graft Versus Host Reaction
55%
Overall Survival
44%
Ciclosporin
33%
Thymocyte Antibody
33%
Disease Free Survival
33%
Recurrence Free Survival
22%
Graft Failure
22%
Infection
11%
Methotrexate
11%
Long Term Survival
11%
Disease Duration
11%
Chronic Graft Versus Host Disease
11%
5 Nitro 2 (3 Phenylpropylamino)benzoic Acid
11%
Keyphrases
Fludarabine-based Conditioning
100%
RBC Concentrate
33%
Random Donor Platelets
16%
GVHD-free Relapse-free Survival
16%
Neuroscience
Fludarabine
100%
Anti-Thymocyte Globulin
33%
Nursing and Health Professions
Fludarabine
100%
Alloimmunization
11%